A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or Leg

Abroad (travel likely)RecruitingPHASE2

Conditions

Sarcoma · Myxofibrosarcoma · Undifferentiated Pleomorphic Sarcoma · Alveolar Soft Part Sarcoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Memorial Sloan Kettering Basking Ridge (Limited protocol activities), Basking Ridge, New Jersey, United States
Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey, United States
Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
Memorial Sloan Kettering Cancer Center @ Suffolk - Commack (Limited Protocol Activities), Commack, New York, United States
Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison, New York, United States
Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Contact: Study coordinator (Edmund Bartlett, MD) · 212-639-2448
Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale, New York, United States
Contact: Study coordinator (Edmund Barlett, MD) · 212-639-2448

Study leads

Edmund Bartlett, MD
Principal Investigator
Memorial Sloan Kettering Cancer Center

View source on ClinicalTrials.gov Contact study team (email)